Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-16-128066)

Filing Details

Accession Number:: 0001209191-16-128066
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-06-15 19:29:17
Reporting Period:: 2016-06-13

Filing Date:: 2016-06-15
Accepted Time:: 2016-06-15 19:29:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1479290	Revance Therapeutics Inc.	RVNC	Pharmaceutical Preparations (2834)	770551645

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1597578	Curtis Ruegg	C/O Revance Therapeutics, Inc. 7555 Gateway Boulevard Newark CA 94560	Evp, Technical Operations	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-06-13	1,000	$8.70	24,944	No	4	M	Direct
Common Stock	Disposition	2016-06-13	1,000	$18.25	23,944	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2016-06-13	1,000	$0.00	1,000	$8.70

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
48,836		2023-05-26	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Ruegg on March 16, 2015.
The shares subject to this Option vest in 48 equal monthly installments over 4 years following May 27, 2013.